STAGE II BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7
Clinical trials for STAGE II BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE II BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE II BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug shows promise in preventing bladder cancer recurrence
Disease control OngoingThis study tests whether pembrolizumab, an immunotherapy drug that helps the immune system fight cancer, can prevent bladder or urinary tract cancer from returning after surgery. About 739 people with muscle-invasive or locally advanced urothelial cancer took part. The drug is gi…
Matched conditions: STAGE II BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:52 UTC
-
Immunotherapy combo shows promise for tough bladder cancer
Disease control OngoingThis early-phase study tested two immunotherapy drugs (durvalumab and tremelimumab) given before surgery to people with muscle-invasive bladder cancer who cannot receive standard chemotherapy. The main goal was to check safety and side effects. Researchers also looked at whether …
Matched conditions: STAGE II BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:56 UTC